5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000928300.84715.89 |
| _version_ | 1797279749604638720 |
|---|---|
| author | B. Andemariam A. Inati R. Colombatti C. Minniti C. Brown M. Hottmann S. Gray C. Hoppe M. Davis P. Yue |
| author_facet | B. Andemariam A. Inati R. Colombatti C. Minniti C. Brown M. Hottmann S. Gray C. Hoppe M. Davis P. Yue |
| author_sort | B. Andemariam |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:30:29Z |
| format | Article |
| id | doaj.art-6940aa1e270b4c039cadaf50efce2a1f |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:30:29Z |
| publishDate | 2023-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-6940aa1e270b4c039cadaf50efce2a1f2024-03-03T11:03:25ZengWileyHemaSphere2572-92412023-04-017S1232410.1097/01.HS9.0000928300.84715.89202304001-000435572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASEB. AndemariamA. InatiR. ColombattiC. MinnitiC. BrownM. HottmannS. GrayC. HoppeM. DavisP. Yuehttp://journals.lww.com/10.1097/01.HS9.0000928300.84715.89 |
| spellingShingle | B. Andemariam A. Inati R. Colombatti C. Minniti C. Brown M. Hottmann S. Gray C. Hoppe M. Davis P. Yue 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE HemaSphere |
| title | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_full | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_fullStr | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_full_unstemmed | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_short | 5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
| title_sort | 5572697 trials in progress the thrive studies evaluating the efficacy safety and long term treatment with inclacumab a p selectin inhibitor in patients with sickle cell disease |
| url | http://journals.lww.com/10.1097/01.HS9.0000928300.84715.89 |
| work_keys_str_mv | AT bandemariam 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT ainati 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT rcolombatti 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT cminniti 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT cbrown 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT mhottmann 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT sgray 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT choppe 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT mdavis 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT pyue 5572697trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease |